July 21, 2016 / 11:37 PM / a year ago

BRIEF-Resverlogix Corp announces dosing of first two patients in expanded renal and orphan programs

July 21 (Reuters) - Resverlogix Corp :

* Results are expected in second half of 2016 from phase 1 study

* Resverlogix announces dosing of first two patients in expanded renal and orphan programs

Source text for Eikon:

Further company coverage: (Reporting by Parikshit Mishra)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below